Vir Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:VIR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Nov 24	SellUS$10,107	Vanina de Verneuil	Individual	1,403	US$7.20
11 Jun 24	SellUS$43,789	Sona Saira Ramasastry	Individual	4,000	US$10.95
03 Apr 24	SellUS$690,365	Marianne De Backer	Individual	72,995	US$9.46
01 Apr 24	SellUS$27,251	Ann Hanly	Individual	2,711	US$10.05
27 Mar 24	SellUS$59,404	Sung Lee	Individual	6,008	US$9.89
22 Feb 24	SellUS$100,737	George Scangos	Individual	10,028	US$10.05
22 Feb 24	SellUS$146,344	Phillip Pang	Individual	14,568	US$10.05
22 Feb 24	SellUS$123,521	Ann Hanly	Individual	12,296	US$10.05
16 Feb 24	SellUS$34,006	Phillip Pang	Individual	3,321	US$10.24
16 Feb 24	SellUS$111,386	George Scangos	Individual	10,878	US$10.24

Insider Trading Volume

Insider Buying: VIR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VIR?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	10,000	0.00726%
State or Government	38,041	0.0276%
Individual Insiders	7,004,431	5.09%
Public Companies	8,550,954	6.21%
General Public	20,331,348	14.8%
VC/PE Firms	29,600,704	21.5%
Institutions	72,184,642	52.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.

Top Shareholders

Top 25 shareholders own 72.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.1%	SB Investment Advisers (UK) Limited	16,684,041	US$112.5m	0%	0.73%
11.9%	BlackRock, Inc.	16,434,122	US$110.8m	0%	no data
9.54%	The Vanguard Group, Inc.	13,135,956	US$88.5m	2.23%	no data
9.38%	Arch Venture Partners, L.P.	12,916,663	US$87.1m	0%	10.05%
6.21%	GSK plc	8,550,954	US$57.6m	0%	no data
4.08%	State Street Global Advisors, Inc.	5,625,533	US$37.9m	10.4%	no data
2.78%	George Scangos	3,834,548	US$25.8m	0.21%	no data
2.59%	OrbiMed Advisors LLC	3,573,000	US$24.1m	54%	0.4%
1.73%	Baillie Gifford & Co.	2,383,029	US$16.1m	-39.2%	0.01%
1.59%	Geode Capital Management, LLC	2,188,774	US$14.8m	0.24%	no data
1.13%	Bill & Melinda Gates Foundation Trust	1,559,142	US$10.5m	0%	0.03%
0.96%	Vicki Sato	1,323,351	US$8.9m	0%	no data
0.88%	Dimensional Fund Advisors LP	1,212,105	US$8.2m	90.1%	no data
0.86%	Renaissance Technologies LLC	1,182,300	US$8.0m	-11.1%	0.01%
0.82%	Charles Schwab Investment Management, Inc.	1,134,276	US$7.6m	13.6%	no data
0.8%	Millennium Management LLC	1,104,716	US$7.4m	-11.5%	0.01%
0.79%	Jefferies Group LLC, Asset Management Arm	1,085,210	US$7.3m	0%	0.17%
0.71%	JP Morgan Asset Management	981,807	US$6.6m	6.09%	no data
0.71%	Voloridge Investment Management, LLC	975,300	US$6.6m	-20.4%	0.03%
0.68%	D. E. Shaw & Co., L.P.	930,655	US$6.3m	0.88%	0.01%
0.64%	Northern Trust Global Investments	878,924	US$5.9m	5.45%	no data
0.55%	Morgan Stanley, Investment Banking and Brokerage Investments	755,349	US$5.1m	-48.8%	no data
0.52%	Goldman Sachs Group, Investment Banking and Securities Investments	721,971	US$4.9m	56.5%	no data
0.48%	Bridgeway Capital Management, LLC	659,562	US$4.4m	-48.6%	0.08%
0.47%	BNY Asset Management	642,283	US$4.3m	-21%	no data